TransForm Pharmaceuticals, Inc. And University of South Florida Announce Collaboration To Improve Drug Performance Through Co-crystals
10/19/2005 5:11:06 PM
TransForm Pharmaceuticals, Inc. (TransForm) today announced a major collaborative effort with University of South Florida (USF) in Tampa, FL in the design and discovery of pharmaceutical co-crystal structures to enhance drug properties. Pharmaceutical co-crystals, a newly recognized category of small molecule pharmaceutical physical forms, can impact the physical-chemical properties of a drug by improving properties such as solubility, dissolution rate, stability and processing. A review of the field of pharmaceutical co-crystals entitled "Crystal Engineering of the Composition of Pharmaceutical Phases. Do Pharmaceutical Co-crystals Represent a New Path to Improved Medicines?" is currently available on-line at www.rsc.org and will appear in print in Chemical Communications, a publication of the Royal Society of Chemistry, in Issue 17 scheduled to publish on September 7, 2004.
comments powered by